009290.KS
Kwang Dong Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 6,310.00
−0.94%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- —
- Revenue estimate
- KRW 244.3B
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- KRW 54
- EPS estimate
- —
- Revenue actual
- KRW 439.8B
- Revenue estimate
- KRW 244.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 2
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | — | KRW 54 | — | KRW 439.8B |
| May 15, 2026 | — | KRW 89 | — | KRW 410.9B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026